Cosentyx 300 MG dose-2 syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F5U1A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,888
Award facts
- Contract value 100% obligated
- $29,887.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,887.69 to AmerisourceBergen Drug Corp for 2 mL syringes of Cosentyx 300 mg dose. The contract was competitively awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, and carries firm fixed pricing. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability across multiple therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies. As a prime vendor under the DLA Troop Support Medical contract, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Cosentyx, a biologic treatment for immunological conditions, exemplifies the company's role in supporting military healthcare procurement needs through competitive federal contracting.
Quick answers
Who was awarded contract SPE2DR26F5U1A?
SPE2DR26F5U1A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F5U1A worth?
The government has obligated $29,888 on SPE2DR26F5U1A.
Is contract SPE2DR26F5U1A an order under another contract?
Yes. SPE2DR26F5U1A is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5U1A competed?
The extent of competition for SPE2DR26F5U1A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award